The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

A new study published in Nature says air pollution may be driving lung cancer development in people who have little to no ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

Although smoking remains the biggest risk factor for lung cancer, it's estimated that nearly 6,000 people who have never ...

A rare cell in the lining of lungs is fundamental to the organ-wide response necessary to repair damage from toxins like ...

Pedro Valencia, VP, asset strategy, leadership, oncology, AbbVie, outlines how the company is accelerating development across ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and ...

The positive CHMP opinion is based on data from the CABINET Phase III trial, which investigated Cabometyx versus placebo in people living with advanced pNETs or epNETs, whose disease had progressed ...

Cancers. 2022, 14 (19), 4769. 10 Frilling et al. Neuroendocrine tumor disease: an evolving landscape. 2012. 19:R163-R185 11 Survival Rates for Gastrointestinal Carcinoid Tumors. ACS website.

Atypical carcinoid tumors grow faster, and they’re more likely to spread, or metastasize, outside of the lungs. Doctors also refer to lung carcinoid tumors based on their location.

Large cell neuroendocrine carcinoma of the lung is a rare and aggressive form of lung cancer, exhibiting characteristics of both small-cell and non-small-cell lung cancers, according to the National ...